SCHEMBL5584927

SCHEMBL5584927

CC(N)C(Cc1ccc(Cl)cc1)Oc1ccccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.49
SLC6A3 Q01959 2/20 0.49
SLC6A4 P31645 2/20 0.43
CNR1 P21554 1/20 0.41
GHSR Q92847 1/20 0.40
PPARA Q07869 2/20 0.38
CSNK2A1 P68400 2/20 0.38
PTGES2 Q9H7Z7 1/20 0.38
CYP2D6 P10635 1/20 0.38
SCN4A P35499 1/20 0.37
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
PPARG P37231 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5585131 0.82 SLC6A2 (0.51) SLC6A2SLC6A3SLC6A4PPARACYP2D6
SCHEMBL5584846 0.80 SLC6A2 (0.56) SLC6A2SLC6A3SLC6A4PPARAPPARG
SCHEMBL3520897 0.76 SLC6A2 (0.60) SLC6A2SLC6A3SLC6A4PTGES2CYP2D6
SCHEMBL5584867 0.75 CNR1 (0.50) CNR1
SCHEMBL5585207 0.73 PPARG (0.55) SLC6A2SLC6A3SLC6A4PPARAPPARG
SCHEMBL3518543 0.73 SLC6A2 (0.56) SLC6A2SLC6A3SLC6A4PTGES2CYP2D6
SCHEMBL6482148 0.71 ADRA2A (0.46) SLC6A2SLC6A3SLC6A4CSNK2A1CYP2D6
SCHEMBL3520850 0.71 SLC6A2 (0.53) SLC6A2SLC6A3SLC6A4PPARACYP2D6
SCHEMBL5585134 0.71 SLC6A2 (0.53) SLC6A2SLC6A3SLC6A4CNR1PTGES2
SCHEMBL5147291 0.71 PPARA (0.72) PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070105914-A1 Substituted sulfonamides MERCK SHARP & DOHME CORP. 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105914-A1 Substituted sulfonamides CNR2, CNR1, FAAH SLC6A2 906/4885SLC6A3 1482/4885SLC6A4 1052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.